Biblio Discovery — Demo Discovery Service

4 results for "Benjamin Besse"

Showing 1–4 · 1.09 seconds · RSS

  1. Journal Article Full text

    Crystal digital droplet PCR for detection and quantification of circulating EGFR sensitizing and resistance mutations in advanced non-small cell lung cancer

    Cécile Jovelet; Jordan Madic; Jordi Remon et al.

    PLOS ONE, Vol. 12 No. 8 · 2017 · English · PLOS Scopus

    Over the past years, targeted therapies using tyrosine kinase inhibitors (TKI) have led to an increase in progression-free survival and response rate for a subgroup of non-small cell lung cancer (NSCLC) patients harbouring specific gene abnormalities compared with chemotherapy. However long-lasting…

  2. Journal Article Full text

    Neutrophilia as prognostic biomarker in locally advanced stage III lung cancer

    Antoine Schernberg; Laura Mezquita; Angela Boros et al.

    PLOS ONE, Vol. 13 No. 10 · 2018 · English · PLOS Scopus

    Objective: To study the prognostic value of baseline leukocytosis or neutrophiliain two retrospective cohorts of stage III Non-Small Cell Lung Cancer (NSCLC) patients. Materials and methods: Clinical records of consecutive previously untreated NSCLC patients in our Institution between June 2001 and…

  3. Journal Article Full text

    Outcomes in oncogenic-addicted advanced NSCLC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assay

    Jordi Remon; Aurelie Swalduz; David Planchard et al.

    PLOS ONE, Vol. 15 No. 6 · 2020 · English · PLOS Scopus

    Circulating tumor DNA (ctDNA)-based molecular profiling is rapidly gaining traction in clinical practice of advanced cancer patients with multi-gene next-generation sequencing (NGS) panels. However, clinical outcomes remain poorly described and deserve further validation with personalized treatment…

  4. Journal Article Full text

    PRognostic and predictive potential Of multiparametric dynamic whole-body 18F-FDG PET Imaging using a Long axial field-of-view (LAFOV) system for FIRST-line chemo-immunotherapy efficacy in advanced non-small cell lung cancer: PROFIL-1 study protocol

    Margaux Geier; Karim Amrane; David Bourhis et al.

    PLOS One, Vol. 21 No. 4 · 2026 · English · PLOS Scopus

    Background: Revolution of chemo-immunotherapy (CT-IO) in the first-line treatment of metastatic non-small-cell lung cancers (NSCLC) without actionable genomic alterations (AGAs) has dramatically improved prognosis, providing long response in a subset of patients. Due to the highly heterogeneous…